DALE Pharma
De berekende faillissementskans van DALE Pharma over 12 maanden bedraagt 3,8% (gemiddeld). De jaarrekening over 2023 toont een eigen vermogen van €606k en een nettoresultaat van €716. De solvabiliteit is beter dan 52% van 779 sectorgenoten (boekjaar 2023). Het bedrijf is actief sinds 2022 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen.
| Eigen vermogen | €606k |
| Netto resultaat | €716 |
| Werknemers (VTE) | 17,6 |
| Beter dan sector | 52% |
Gemengd profiel: sterk in stabiliteit, zwakker in rentabiliteit.
Statistische inschatting op basis van openbare bronnen, geen kredietadvies of vaststelling. Hoe berekenen we dit?
De volledige opbouw van de score, de scoregeschiedenis per boekjaar en de indicatieve kredietlimiet ontgrendel je met Plus.
Bekijk plannen →| Kengetal | Dit bedrijf | Sectormediaan | Positie in de sector |
|---|---|---|---|
| Solvabiliteit | 19,6% | 17,7% | |
| Nettoresultaat | €716 | €12k | |
| Eigen vermogen | €606k | €80k | |
| Bruto bedrijfsmarge | €1,30M | €164k | |
| Personeelskosten | €1,20M | €191k |
| Boekjaar | 2023 |
|---|---|
| Omzet | €3,28M |
| EBITDA | €95k |
| Nettoresultaat | €716 |
| Cashflow | €51k |
| Personeelskosten | €1,20M |
| Belastingen op het resultaat | - |
| Dividenden | - |
| Totaal activa | €3,08M |
| Eigen vermogen | €606k |
| Schulden | €2,48M |
| waarvan ≤ 1 jaar | €1,75M |
| waarvan > 1 jaar | €721k |
| Werkkapitaal | €995k |
| Werknemers (VTE) | 17,6 |
| 2023 | |
|---|---|
| Current ratio | 1,57 |
| Quick ratio | 0,82 |
| Werkkapitaalratio | 32,2% |
| Solvabiliteit | 19,6% |
| Debt / equity | 4,09 |
| Langetermijnschuldgraad | 1,19 |
| Interest coverage | 2,17 |
| Bruto rentabiliteit | 2,8% |
| Netto rentabiliteit | 0,0% |
| ROA | 0,0% |
| ROE | 0,1% |
| EBITDA-marge | 2,9% |
| Klantenkrediet (DSO) | 151d |
| Leverancierskrediet (DPO) | 133d |
| Voorraadrotatie | 2,45 |
| Voorraaddagen (DSI) | 149d |
| Post | Code | 2023 |
|---|---|---|
| Balans, Activa | ||
| TOTAAL ACTIVA | 20/58 | €3,08M |
| Vaste activa | 21/28 | €338k |
| Oprichtingskosten | 20 | €0 |
| Immateriële vaste activa | 21 | €192k |
| Materiële vaste activa | 22/27 | €146k |
| Financiële vaste activa | 28 | €363 |
| Vlottende activa | 29/58 | €2,75M |
| Voorraden en bestellingen in uitvoering | 3 | €1,30M |
| Vorderingen op ten hoogste één jaar | 40/41 | €1,41M |
| Geldbeleggingen | 50/53 | €0 |
| Liquide middelen | 54/58 | €34k |
| Balans, Passiva | ||
| TOTAAL PASSIVA | 10/49 | €3,08M |
| Eigen vermogen | 10/15 | €606k |
| Inbreng / kapitaal | 10/11 | €605k |
| Overgedragen winst (verlies) | 14 | €716 |
| Schulden | 17/49 | €2,48M |
| Schulden op meer dan één jaar | 17 | €721k |
| Schulden op ten hoogste één jaar | 42/48 | €1,75M |
| Handelsschulden op ten hoogste één jaar | 44 | €1,16M |
| Resultatenrekening | ||
| Omzet | 70 | €3,28M |
| Bruto bedrijfsmarge | 9900 | €1,30M |
| Bedrijfsresultaat | 9901 | €44k |
| Financiële opbrengsten | 75 | €0 |
| Financiële kosten | 65 | €44k |
| Resultaat vóór belasting | 9903 | €716 |
| Resultaat van het boekjaar | 9904 | €716 |
| Te bestemmen resultaat | 9905 | €716 |
| NACE primair | Detailhandel(47120) |
| Rechtsvorm | BV(610) |
| Oprichtingsdatum | 04-10-2022 |
| Status | Actief |
| Postcode | 7850 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 55010D0046/00H000 | Wallonië | 239 m² | 1 · 118 m² | - |
| 92007F0104/00H002 | Wallonië | 229 m² | 1 · 67 m² | 13,8 m · 4 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
12-09-2024 Zetelverplaatsing van Chapelle-lez-Herlalmont naar Enghien
- Rue Joseph Francq 1 boîte 4-7160 Chapelle-lez-Herlalmont - Belgique → THE MUG ENGHIEN - Grand-Place 50 -7850 Enghien
Technische details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "THE MUG ENGHIEN - Grand-Place 50 -7850 Enghien",
"city": "Enghien",
"region": "waals_gewest",
"street": "Grand-Place",
"country": "BE",
"postcode": "7850",
"box_number": null,
"street_number": "50",
"locality_suffix": null
},
"old_address": {
"raw": "Rue Joseph Francq 1 bo\u00EEte 4-7160 Chapelle-lez-Herlalmont - Belgique",
"city": "Chapelle-lez-Herlalmont",
"region": "waals_gewest",
"street": "Rue Joseph Francq",
"country": "BE",
"postcode": "7160",
"box_number": "4",
"street_number": "1",
"locality_suffix": null
},
"effective_date": "2024-07-01",
"evidence_quote": "L\u0027assembl\u00E9e accepte \u00E0 l\u0027unanimit\u00E9 le transfert du si\u00E8ge social vers l\u0027adresse THE MUG ENGHIEN - Grand-Place 50 -7850 Enghien, en date du 01/07/2024.",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": null,
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-09-12",
"filing_date": "2024-09-03",
"act_kind_objet": "Transfert de si\u00E8ge"
},
"decision": {
"body": "assembl\u00E9e g\u00E9n\u00E9rale extraordinaire",
"date": "2024-06-20",
"unanimous": true
},
"subject_company": {
"kbo": "0791.839.803",
"name_full": "DALE Pharma",
"legal_form": "SRL",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Didier P\u00EAtre",
"org_rep_person_name": null,
"person_role_at_subject": "Administrateur"
},
"co_filed_documents": [
"Mod DOC 19.01"
]
}01-08-2023 Kapitaalverhoging van €300.750 tot €300.750
- €0 → €300.750
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 300750.0,
"delta_eur": 300750.0,
"before_eur": 0.0,
"_arith_derived": "before",
"share_emission": {
"agio_eur": null,
"share_form": "nominal",
"share_class": null,
"n_new_shares": 250,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 1203.0
},
"decrease_purpose": null,
"contribution_type": "numeraire",
"paid_up_delta_eur": 300750.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "create"
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "BERQUIN NOTAIRES",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2023-08-01",
"filing_date": "2023-07-28",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2023-07-25",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": true,
"firm_kbo": null,
"firm_name": null,
"ibr_number": null,
"mission_type": null,
"individual_name": null
},
"subject_company": {
"kbo": "0791.839.803",
"name_full": "DALE Pharma",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition du proc\u00E8s-verbal",
"procuration",
"texte coordonn\u00E9 des statuts"
],
"shareholders_after": [],
"share_classes_after": []
}14-03-2023 Zetelverplaatsing van Bruxelles naar Piéton
- Boulevard de l'Empereur 10-1000 Bruxelles - Belgique → rue Joseph Francq 1 boite 4 à 7160 Piéton
Technische details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "combined",
"new_address": {
"raw": "rue Joseph Francq 1 boite 4 \u00E0 7160 Pi\u00E9ton",
"city": "Pi\u00E9ton",
"region": "waals_gewest",
"street": "rue Joseph Francq",
"country": "BE",
"postcode": "7160",
"box_number": "4",
"street_number": null,
"locality_suffix": null
},
"old_address": {
"raw": "Boulevard de l\u0027Empereur 10-1000 Bruxelles - Belgique",
"city": "Bruxelles",
"region": "brussels_hoofdstedelijk_gewest",
"street": "Boulevard de l\u0027Empereur",
"country": "BE",
"postcode": "1000",
"box_number": null,
"street_number": "10",
"locality_suffix": null
},
"effective_date": "2022-12-01",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale propose de modifier le si\u00E8ge de la soci\u00E9t\u00E9 situ\u00E9 actuellement sis boulevard de l\u0027empereur 10 \u00E0 1000 Bruxelles vers le si\u00E8ge d\u0027exploitation situ\u00E9e sis rue Joseph Francq 1 boite 4 \u00E0 7160 Pi\u00E9ton.",
"region_changed": true,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": true,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": null,
"filing_date": "2023-03-06",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"date": null,
"unanimous": true
},
"subject_company": {
"kbo": "0791.839.803",
"name_full": "DALE Pharma",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "DIDIER P\u00CATRE",
"org_rep_person_name": null,
"person_role_at_subject": "Administrateur"
},
"co_filed_documents": [
"Copie \u00E0 publier aux annexes au Moniteur belge apr\u00E8s d\u00E9p\u00F4t de l\u0027acte au greffe"
]
}22-02-2023 1 bestuurder benoemd, 2 ontslagnemend
- Emilie Dewerpe, Bestuurder
- Aurélie Wattiez, Bestuurder
- Liouba Muzzin, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Aur\u00E9lie Wattiez",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale valide les d\u00E9missions de Aur\u00E9lie Wattiez et Liouba Muzzin er\u0131 tant qu\u0027administrateur de",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Liouba Muzzin",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale valide les d\u00E9missions de Aur\u00E9lie Wattiez et Liouba Muzzin er\u0131 tant qu\u0027administrateur de",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Emilie Dewerpe",
"address": "rue de la concorde 68 \u00E0 7100 La Louvi\u00E8re",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Emilie Dewerpe domicili\u00E9e rue de la concorde 68 \u00E0 7100 La Louvi\u00E8re est propos\u00E9e comme administrateur",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Aur\u00E9lie Wattiez",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale valide les d\u00E9missions de Aur\u00E9lie Wattiez et Liouba Muzzin er\u0131 tant qu\u0027administrateur de",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Liouba Muzzin",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale valide les d\u00E9missions de Aur\u00E9lie Wattiez et Liouba Muzzin er\u0131 tant qu\u0027administrateur de",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Emilie Dewerpe",
"address": "rue de la concorde 68 \u00E0 7100 La Louvi\u00E8re",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Emilie Dewerpe domicili\u00E9e rue de la concorde 68 \u00E0 7100 La Louvi\u00E8re est propos\u00E9e comme administrateur",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2023-02-22",
"filing_date": null,
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2023-02-13",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2023-02-13",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0791.839.803",
"name_full": "DALE Pharma",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamFR | DALE Pharma |